XPO, Inc.
$25.96B- Market cap
- $22.86B
- Debt
- +$3.41B
- Cash
- −$310.00M
Capital structure 87% equity / 13% debt · EV / Revenue 3.18x · EV / EBITDA 35.86x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $22.86B · View financials
Snapshot Sep 8, 9:47 AM ET
FY 2025 · Mkt cap
Decision snapshot: XPO stock price at discount vs IONS $195.26 current versus $712.65 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IONS's multiple
Implied fair value · at XPO's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: XPO FY 2025 (ended Dec 31, 2025) · IONS FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 87% equity / 13% debt · EV / Revenue 3.18x · EV / EBITDA 35.86x
Capital structure 81% equity / 19% debt · EV / Revenue 9.77x
XPO carries the larger enterprise value at $25.96B against $9.22B; XPO trades on the lower EV / Revenue multiple (3.18x vs 9.77x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
XPO, Inc. · implied price per share
Bear
-$17.35
Base
-$15.65
Bull
-$13.36
Ionis Pharmaceuticals, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.83x
4.59x
Net debt / EBITDA
Leverage against operating earnings
4.28x
1.34x
Cash and equivalents
Liquid reserves on the balance sheet
$310.00M
$2.68B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
C. H. ROBINSON WORLDWIDE, INC.
XPO vs CHRW
Hub Group, Inc.
XPO vs HUBG
SAIA INC
XPO vs SAIA
OLD DOMINION FREIGHT LINE, INC.
XPO vs ODFL
FEDEX CORP
XPO vs FDX
UNITED PARCEL SERVICE INC
XPO vs UPS
Sarepta Therapeutics, Inc.
XPO vs SRPT
Moderna, Inc.
XPO vs MRNA
Natera, Inc.
XPO vs NTRA
ILLUMINA, INC.
XPO vs ILMN
AMGEN INC
XPO vs AMGN
VERTEX PHARMACEUTICALS INC / MA
XPO vs VRTX
$3.41B
$2.24B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.